CEL-SCI Corp (CVM):企業の財務・戦略的SWOT分析

◆英語タイトル:CEL-SCI Corp (CVM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH37979FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年2月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

CEL-SCI Corp (CVM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacture of compound biological substances. CEL-SCI’s lead candidate, Multikine (leukocyte interleukin), is an investigational immunotherapy against cancer and human papilloma virus (HPV). The company is also investigating an immunotherapy (LEAPS-H1N1-DC) as a possible treatment for H1N1 in hospitalized patients and vaccines, CEL-2000 and CEL-4000 for rheumatoid arthritis using Ligand Epitope Antigen Presentation System (LEAPS) technology platform. CEL-SCI is headquartered in Vienna, Virginia, the US.

CEL-SCI Corp Key Recent Developments

Feb 16,2021: CEL-SCI reports first quarter fiscal 2021 financial results
Dec 30,2020: CEL-SCI reports fiscal 2020 financial results and clinical & corporate developments
Aug 11,2020: CEL-SCI reports third quarter fiscal 2020 financial results
May 11,2020: CEL-SCI reports second quarter fiscal 2020 financial results
Mar 24,2020: Covid-19: CEL-SCI to develop therapy; Soligenix works on vaccine

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
CEL-SCI Corp – Key Facts
CEL-SCI Corp – Key Employees
CEL-SCI Corp – Key Employee Biographies
CEL-SCI Corp – Major Products and Services
CEL-SCI Corp – History
CEL-SCI Corp – Company Statement
CEL-SCI Corp – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
CEL-SCI Corp – Business Description
CEL-SCI Corp – Corporate Strategy
CEL-SCI Corp – SWOT Analysis
SWOT Analysis – Overview
CEL-SCI Corp – Strengths
CEL-SCI Corp – Weaknesses
CEL-SCI Corp – Opportunities
CEL-SCI Corp – Threats
CEL-SCI Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
CEL-SCI Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
CEL-SCI Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
CEL-SCI Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 16, 2021: CEL-SCI reports first quarter fiscal 2021 financial results
Dec 30, 2020: CEL-SCI reports fiscal 2020 financial results and clinical & corporate developments
Aug 11, 2020: CEL-SCI reports third quarter fiscal 2020 financial results
May 11, 2020: CEL-SCI reports second quarter fiscal 2020 financial results
Mar 24, 2020: Covid-19: CEL-SCI to develop therapy; Soligenix works on vaccine
Mar 09, 2020: CEL-SCI initiates development of immunotherapy to treat COVID-19 coronavirus infection
Feb 10, 2020: CEL-SCI reports first quarter fiscal 2020 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
CEL-SCI Corp, Key Facts
CEL-SCI Corp, Key Employees
CEL-SCI Corp, Key Employee Biographies
CEL-SCI Corp, Major Products and Services
CEL-SCI Corp, History
CEL-SCI Corp, Key Competitors
CEL-SCI Corp, Ratios based on current share price
CEL-SCI Corp, Annual Ratios
CEL-SCI Corp, Annual Ratios (Cont...1)
CEL-SCI Corp, Interim Ratios
CEL-SCI Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
CEL-SCI Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
CEL-SCI Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[CEL-SCI Corp (CVM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Greatcell Solar Ltd (GSL):企業の財務・戦略的SWOT分析
    Greatcell Solar Ltd (GSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • SVB Financial Group:企業のM&A・事業提携・投資動向
    SVB Financial Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SVB Financial Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • AS Kevelt-製薬・医療分野:企業M&A・提携分析
    Summary AS Kevelt (Kevelt), a subsidiary of Pharmsynthez is a healthcare company that develops, manufactures and markets drug products. The company offers products which include concentrate solutions for infusion, endocervical gel, eye drops and other solutions. It also offers sub-contracting and di …
  • VVC Exploration Corp (VVC):企業の財務・戦略的SWOT分析
    Summary VVC Exploration Corp (VVC) is a mining and mineral exploration company. It is involved in acquisition, exploration, and development of gold, copper, silver, and other mineral properties. Its projects portfolio includes Gloria, Cumeral, La Tuna, and Timmins projects. VVC also offers open-pit …
  • Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析
    Chenguang Biotech Group Co Ltd (300138) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Avery Dennison Corporation (AVY):企業の財務・戦略的SWOT分析
    Avery Dennison Corporation (AVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sharp Corporation (6753)-エネルギー分野:企業M&A・提携分析
    Summary Sharp Corporation (Sharp) is involved in designing, development, manufacturing, and marketing of digital information equipments, health and environmental equipments, energy and business solutions. The company’s major products include refrigerators, microwave ovens, air conditioners, washing …
  • Adenovir Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Adenovir Pharma AB (Adenovir Pharma) focuses on the development of antiviral pharmaceutical solutions for the treatment of infectious eye diseases such as adenoviral conjunctivitis and epidemic keratoconjunctivitis (EKC). The company’s APD-209 is topical pharmaceutical product that prevents …
  • Indago Energy Ltd (INK):石油・ガス:M&Aディール及び事業提携情報
    Summary Indago Energy Ltd (Indago), formerly Pryme Energy Ltd is a provider of specialist oil and gas production chemicals. The company offers acquisition, up-gradation, exploration and production services to onshore oil and natural gas. It holds interests in the Newkirk project located in Kay Count …
  • Physio-Control Inc:医療機器:M&Aディール及び事業提携情報
    Summary Physio-Control Inc (Physio-Control), a subsidiary of Stryker Corp, is a manufacturer of emergency medical response products. The company offers lifepak monitor and defibrillator, lifepak CR plus AED, lifepak express AED, lifenet system, data review software, chest true cprcoaching device, lu …
  • Akonni Biosystems Inc:企業の製品パイプライン分析2018
    Summary Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company provides product such as nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray reader …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Petroleos Mexicanos (PEMEX):戦略・SWOT・企業財務分析
    Petroleos Mexicanos (PEMEX) - Strategy, SWOT and Corporate Finance Report Summary Petroleos Mexicanos (PEMEX) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Herti AD:企業の戦略・SWOT・財務情報
    Herti AD - Strategy, SWOT and Corporate Finance Report Summary Herti AD - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • CTI Engineering Co Ltd:企業の戦略・SWOT・財務情報
    CTI Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report Summary CTI Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nisshinbo Holdings, Inc.:企業の戦略・SWOT・財務情報
    Nisshinbo Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nisshinbo Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Berger Paints India Ltd (BERGEPAINT):企業の財務・戦略的SWOT分析
    Berger Paints India Ltd (BERGEPAINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Abramson Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Abramson Cancer Center, formerly Penn Medicine's Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of cancer. The center provides supportive care services, which include integrati …
  • Carl Zeiss AG:企業の戦略的SWOT分析
    Carl Zeiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Halliburton Co (HAL):石油・ガス:M&Aディール及び事業提携情報
    Summary Halliburton Co (Halliburton) is an oilfield services company. The company serves the upstream oil and gas industry throughout the lifecycle of the reservoir, from identifying hydrocarbons and managing geological data, to drilling and formation evaluation, well construction and completion, an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆